Why the study?
Does antihypertensive treatment reduce cardiovascular mortality, all-cause mortality, stroke, and heart failure in hypertensive patients over 65 years of age?
Population
114,854 hypertensive patients over 65 years of age from 18 prospective randomized trials. Mean age of…
Comparison
Antihypertensive treatment (various regimens) vs Non-drug control group or alternative…
Design
Meta-analysis, prospective randomized trials
Follow-up
average 3.44 years
Authors
Loading...
Supports antihypertensive treatment in hypertensives over 65; confirms linear SBP-driven reductions in mortality, stroke, and HF.
Does antihypertensive treatment reduce cardiovascular mortality, all-cause mortality, stroke, and heart failure in hypertensive patients over 65 years of age?
Antihypertensive treatment in patients over 65 years of age significantly reduces the risk of stroke, heart failure, and mortality, with the benefit primarily driven by systolic blood pressure reduction.
Briasoulis et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: